Clorox (NYSE:CLX) Posts Earnings Results

Clorox (NYSE:CLX - Get Free Report) issued its earnings results on Monday. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12), Zacks reports. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox's quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the company earned $1.71 earnings per share. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Price Performance

Shares of NYSE:CLX traded up $2.16 on Thursday, reaching $138.64. 565,149 shares of the company traded hands, compared to its average volume of 1,297,858. The company's 50 day moving average is $143.06 and its 200-day moving average is $154.43. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market capitalization of $17.08 billion, a PE ratio of 37.88, a P/E/G ratio of 2.62 and a beta of 0.60. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.52%. Clorox's dividend payout ratio is currently 87.61%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research report on Tuesday. Wells Fargo & Company dropped their target price on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday. UBS Group lowered their price objective on Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a report on Thursday, April 17th. DA Davidson reduced their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Finally, Morgan Stanley lowered their target price on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $151.23.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.